Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...

Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

Your kidneys play a vital role in filtering toxins and maintaining overall health Being aware of these lesser-known symptoms ...

Nivolumab plus cabozantinib improved long-term efficacy and safety vs sunitinib in advanced renal cell carcinoma, per final ...

A recent study on kidney disease found that nearly half of patients with advanced chronic kidney disease (CKD) in the country ...

Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based ...

A recent study on kidney disease found that nearly half of patients with advanced chronic kidney disease (CKD) in the country lost their jobs due to their deteriorating health conditions.

Symptom scores remained stable over time, with similar QOL trends in both treatment arms.

Merck & Co’s – known as MSD outside of the US and Canada – Welireg (belzutifan) has been conditionally approved by the ...